Clinical

Find out how research at St. Jude underlies clinical progress in the care and treatment of cancer, blood disorders, neurological disease and more.

NCCN publishes guidelines for standardized treatment of Wilms tumor

St. Jude Strategic Communication, Education and Outreach Department

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

Cancer care during a pandemic: What we learned prepares us for the next emergency

Dylan Graetz, MD, MPH

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Different types of pediatric cancer treatments are ototoxic, or damaging to the ears. As cancer treatments become more effective and survival rates increase, we’re getting a better picture of how various treatments affect patients later on.

What we’ve found out about hearing loss and cognitive function in children

Johnnie Bass, AuD, PhD

This study, to our knowledge, is the first to objectively measure hearing and neurocognitive function in a large cohort of long-term survivors of childhood cancer stratified by treatment exposures.

Quality sickle cell disease treatment shouldn’t depend upon where you live

The global burden of sickle cell disease: The quality of treatment shouldn’t depend upon where you live

Ayobami Olanrewaju, MD

Survival and quality of life for many with sickle cell disease depends upon where they live. Here’s what a doctor wants to do to fix that.

How do fathers grieve the loss of a child?

Michael J. McNeil, MD

Fathers express grief through keeping busy or focusing on work – different than a mother’s grief. But fathers may not be getting the support they need after the loss of a child.

Cultural humility ensures open, honest patient care

Arshia Madni, MD

Strengthening the doctor-patient bond requires a new way of thinking to help ensure open communication and the best possible care.

COVID-19 prevention is essential for bone marrow transplant patients

Mary Powers

Research points to bone marrow transplant patients having the highest risk for severe complications from a COVID infection. Here’s what that means.

Sickle cell disease and COVID-19: What we’re telling patients

Jane Hankins, MD

Sickle cell disease patients face additional dangers if they become infected with COVID-19. Here’s what this physician specialist is telling her patients.